Table 1.
Sequence-based HLA typing of donors and presence of EBV DNA in their PBMC
| Donor ID | HLA-A | HLA-B | HLA-C | Molecular EBV testing (PBMC) |
|---|---|---|---|---|
| CAU#1 09193-5 | A*0205, 2601 | B*3801, 5801 | C*0701(0706), 12030 | Positive |
| CAU#2 01500-3 | A*0201, 0310 | B*3503, 5701 | C*04, 0602 | Negative |
| CAU#6 23530-1 | A*0201 | B*15 ,44 | C*0102, 05 | Positive |
| CAU#7 19730-0 | A*0101, 3301 | B*1402, 27 | C*0102, 0802 | Negative |
| CAU#8 24311-5 | A*0101, 0201 | B*27, 5701 | C*0202, 0602 | Positive |
| CAU#9 20023-2 | A*0301, 0301 | B*18, 35 | C*04, 07 | Positive |
| CAU#11 20028-1 | A*0101, 2601 | B*0702, 3801 | C*0702, 1203 | Negative |
| CAU#16 25090-9 | A*24, 26 | B*3801, 4002 | C*0202, 1203 | Negative |
| CAU#24 16959-6 | A*0201, 0201 | B*1501, 5701 | C*0102, 0602 | Negative |
| CAU#26 23794-2 | A*0101, 0201 | B*08a, 15a | C*0102, 07 | Positive |
| CHN#3 25088-0 | A*0201, 1101 | B*1301, 5201 | C*0304, 1202 | Negative |
| CHN#4 25097-1 | A*0203, 2402 | B*1502, 4001 | C*0702, 0801 | Positive |
| CHN#5 25100-8 | A*0207, 2402 | B*3802, 4601 | C*0102, 0702 | Negative |
| CHN#10 01772-3 | A*0201, 1101 | B*4001, 4601 | C*0702, 0702 | Positive |
| CHN#12 25299-2 | A*1102, 2402 | B*2704, 4001 | C*1202, 1502 | Negative |
| CHN#13 25249-9 | A*0207, 2402 | B*35, 4601 | C*0102, 0303 | Negative |
| CHN#17 25203-7 | A*1102, 2402 | B*1301, 1302 | C*0304, 0602 | Negative |
| CHN#23 20459-6 | A*1101 | B*1301, 1502 | C*1501, 1602 | Negative |
| CHN#27 25584-1 | A*24, 31 | B*0702, 5801 | C*0302, 0702 | Negative |
| CHN#29 25680-8 | A*1101, 2601 | B*0801, 4001 | C*0304, 0702 | Positive |